Lucid Diagnostics Inc. LUCD

0.83 (0.01) (1.19%) as of 25 Sep
Market cap
$170.3M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

168.79% 152.80% 176.49% 364.89%
ROA
(173.74%) (198.34%) (173.99%) (167.51%)
ROIC
(3,736.30%) (13,430.74%) (2,325.67%) (3,096.53%)
Return on Tangible Assets
(268.77%) (727.89%) (2,017.30%) (655.50%)
Average Days of Receivables
45.64 49.87 48.98 72.93
Free Cash Flow per Share
(0.41) (0.46) (0.33) (0.26)
Free Cash Flow
(44.18) (46.68) (46.44) (47.18)
Capital Expenditures
(0.40) (0.20) (0.32) (0.31)
Piotroski F-Score
4.00 4.00 6.00 6.00
Other line items
Cash ROIC
(45.86%) (66.75%) (80.81%) (69.10%)
Accounts Receivable Turnover
14.94 13.68 13.69 7.45
Accounts Payable Turnover
7.38 6.03 7.08 8.83
Inventory Turnover
12.24 19.22 14.15 13.40
Average Days of Payables
39.41 53.08 58.29 36.74
Days of Inventory on Hand
25.50 19.32 25.38 26.66
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
122.94% 120.65% 106.27% 99.04%
Selling, General and Administrative Expense of Revenue
900.61% 883.49% 813.79% 802.37%
Share Based Compensation of Revenue
102.23% 95.43% 94.90% 99.56%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.66 0.66 0.79 0.72
Depreciation/Fixed assets
1.03 1.08 0.96 1.08
Capex/Depreciation
(0.46) (0.23) (0.37) (0.36)
Revenue per Share
0.04 0.05 0.04 0.03
Operating CF per Share
(0.40) (0.46) (0.33) (0.26)
Capex per Share
0.00 0.00 0.00 0.00
Capex to Sales
0.09 0.04 0.06 0.06
Net Profit Margin
(1,496.79%) (1,499.55%) (1,133.21%) (1,193.87%)

Fold the line items

Columns are period end dates